Trial · NCT03252249
Results by group54
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 54
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Time-to-event: All-cause Mortality | 3 Months Dual Anti-platelet Therapy | 447.337 | Standard Error 1.0542 | days | |
| Time-to-event: All-cause Mortality | 12 Months Dual Anti-platelet Therapy | 445.196 | Standard Error 1.1741 | days | |
| Incidence: All-cause Mortality | 3 Months Dual Anti-platelet Therapy | 68 | Participants | ||
| Incidence: All-cause Mortality | 12 Months Dual Anti-platelet Therapy | 87 | Participants | ||
| Time-to-event: Non-cardiovascular Death (Including Fatal Bleeding) and Major Non-fatal Bleeding | 3 Months Dual Anti-platelet Therapy | 442.881 | Standard Error 1.2908 | days | |
| Time-to-event: Non-cardiovascular Death (Including Fatal Bleeding) and Major Non-fatal Bleeding | 12 Months Dual Anti-platelet Therapy | 440.736 | Standard Error 1.3565 | days | |
| Incidence: Non-cardiovascular Death (Including Fatal Bleeding) and Major Non-fatal Bleeding | 3 Months Dual Anti-platelet Therapy | 104 | participants | ||
| Incidence: Non-cardiovascular Death (Including Fatal Bleeding) and Major Non-fatal Bleeding | 12 Months Dual Anti-platelet Therapy | 127 | participants | ||
| Time-to-event: Non-cardiovascular Death (Including Fatal Bleeding) | 3 Months Dual Anti-platelet Therapy | 452.453 | Standard Error 0.5873 | days | |
| Time-to-event: Non-cardiovascular Death (Including Fatal Bleeding) | 12 Months Dual Anti-platelet Therapy | 452.593 | Standard Error 0.5285 | days | |
| Incidence: Non-cardiovascular Death (Including Fatal Bleeding) | 3 Months Dual Anti-platelet Therapy | 27 | participants | ||
| Incidence: Non-cardiovascular Death (Including Fatal Bleeding) | 12 Months Dual Anti-platelet Therapy | 29 | participants | ||
| Time-to-event: Major Fatal and Non-fatal Bleeding | 3 Months Dual Anti-platelet Therapy | 445.227 | Standard Error 1.1719 | days | |
| Time-to-event: Major Fatal and Non-fatal Bleeding | 12 Months Dual Anti-platelet Therapy | 442.790 | Standard Error 1.2794 | days | |
| Incidence: Major Fatal and Non-fatal Bleeding | 3 Months Dual Anti-platelet Therapy | 80 | participants | ||
| Incidence: Major Fatal and Non-fatal Bleeding | 12 Months Dual Anti-platelet Therapy | 102 | participants | ||
| Time-to-event: Gastrointestinal Bleeding | 3 Months Dual Anti-platelet Therapy | 449.967 | Standard Error 0.8887 | days | |
| Time-to-event: Gastrointestinal Bleeding | 12 Months Dual Anti-platelet Therapy | 450.562 | Standard Error 0.7774 | days | |
| Incidence: Gastrointestinal Bleeding | 3 Months Dual Anti-platelet Therapy | 36 | Participants | ||
| Incidence: Gastrointestinal Bleeding | 12 Months Dual Anti-platelet Therapy | 38 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03252249/results